吸烟类风湿关节炎患者肺癌低剂量CT筛查中肺部异常的检出
在2015至2023年Mass General Brigham医疗系统接受低剂量胸部CT肺癌筛查的患者中,比较228例类风湿关节炎(RA)患者与14,805例无RA对照者。RA与阳性筛查(OR 1.38,95%CI 1.02-1.87)、纤维化改变(OR 1.77,95%CI 1.08-2.91)及支气管扩张(OR 1.64,95%CI 1.12-2.39)相关。约四分之一符合美国预防服务工作组肺癌筛查标准的RA患者筛查阳性,二十分之一发现肺癌。
要点
- RA患者低剂量CT肺癌筛查阳性率为26.8%,无RA者为22.2%(P=0.10)。
- RA与阳性筛查(OR 1.38)、纤维化改变(OR 1.77)、支气管扩张(OR 1.64)相关。
- RA患者肺癌检出率为4.8%,无RA者为3.6%(P=0.33)。
核心结论
- RA患者在以肺癌筛查为目的的低剂量胸部CT中,阳性筛查、纤维化改变和支气管扩张的患病率高于无RA对照者。
- 约四分之一符合美国预防服务工作组肺癌筛查标准的RA患者筛查阳性,约二十分之一发现肺癌。
- 作者认为这些结果强调了对符合条件的RA患者进行肺癌筛查的重要性,并可能为其他肺部异常的筛查策略提供信息。
研究设计与样本
- 研究为在Mass General Brigham医疗系统内进行的多医院系统研究,纳入2015至2023年间连续接受临床指征低剂量胸部CT肺癌筛查的患者。
- 共识别228例RA患者和14,805例无RA对照者,比较两组肺部结节、阳性筛查、纤维化肺改变、支气管扩张和肺癌的患病率。
- 采用多变量逻辑回归分析RA与各肺部异常之间的关联。
主要发现
- RA患者阳性筛查率为26.8%,无RA对照者为22.2%(P=0.10)。
- RA患者肺癌检出率为4.8%,无RA对照者为3.6%(P=0.33)。
- 多变量模型中,RA与阳性筛查相关(OR 1.38,95%CI 1.02-1.87)。
- 多变量模型中,RA与纤维化肺改变相关(OR 1.77,95%CI 1.08-2.91)。
- 多变量模型中,RA与支气管扩张相关(OR 1.64,95%CI 1.12-2.39)。
关键数值与推荐
- 阳性筛查定义为需要进一步影像学检查或活检的结节。
- 美国预防服务工作组肺癌筛查标准为原文提及的筛查资格标准。
临床怎么用
- 作者认为这些结果强调了对符合条件的RA患者进行肺癌筛查的重要性。
- 作者认为这些结果可能为其他肺部异常的筛查策略提供信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Rheumatoid arthritis (RA) is associated with interstitial lung disease, bronchiectasis, rheumatoid lung nodules, and lung cancer. Recent guidelines proposed criteria for lung disease screening in RA, but the prevalence of abnormal lung findings in patients with RA is unknown. METHODS: Among all patients screened for lung cancer with low-dose chest computed tomography (CT) in the Mass General Brigham health care system between 2015 and 2023, we identified patients with and without RA. We compared the prevalence of lung nodules, "positive screen" (nodules requiring further imaging or biopsy), fibrotic lung changes, bronchiectasis, and lung cancer between patients with RA and comparators without RA using multivariable logistic regression. RESULTS: Among consecutive patients screened for lung cancer with clinically indicated low-dose chest CT, we identified 228 patients with RA and 14,805 comparators without RA. "Positive screens" were noted in 26.8% of patients with RA and 22.2% of patients without RA (P = 0.10). Lung cancer was found in 4.8% of patients with RA and 3.6% of patients without RA (P = 0.33). In multivariable models, RA was associated with positive screen (odds ratio [OR] 1.38, 95% confidence interval [CI] 1.02-1.87), fibrotic lung changes (OR 1.77, 95% CI 1.08-2.91), and bronchiectasis (OR 1.64, 95% CI 1.12-2.39). CONCLUSION: Patients with RA had higher prevalence of positive screening, fibrotic changes, and bronchiectasis detected by low-dose chest CT performed for lung cancer screening. Approximately one in four patients with RA who met US Preventive Services Task Force lung cancer screening criteria had a positive screen, whereas 1 in 20 had lung cancer. These results emphasize the importance of lung cancer screening among eligible patients with RA and may inform screening strategies for other lung abnormalities.
引用
- McDermott GC, Hammer M, Wang X, et al. Detection of Lung Abnormalities in Patients With Rheumatoid Arthritis Who Smoke and Who Were Screened for Lung Cancer With Low-Dose Chest Computed Tomography Imaging in Routine Clinical Care: Results From a Large Multihospital System. Arthritis Care Res (Hoboken). 2026. PMID: 41144903. doi:10.1002/acr.25680
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。